Dimensional Fund Advisors
MCRB icon

Dimensional Fund Advisors’s Seres Therapeutics MCRB Stock Holding History

Dimensional Fund Advisors’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,092
Closed -$122 – 3487
2022
Q4 		$122 Sell
1,092
-682
-38% -$91.4K ﹤0.01% 3302
2022
Q3 		$228K Sell
1,774
-25,364
-93% -$2.6M ﹤0.01% 3215
2022
Q2 		$1.86M Buy
27,138
+3,722
+16% +$321K ﹤0.01% 2761
2022
Q1 		$3.33M Buy
+23,416
New +$3.6M ﹤0.01% 2665
2017
Q4 		– Sell
-1,785
Closed -$573K – 3332
2017
Q3 		$573K Sell
1,785
-45
-2% -$12.3K ﹤0.01% 3086
2017
Q2 		$414K Buy
1,830
+574
+46% +$118K ﹤0.01% 3119
2017
Q1 		$283K Buy
+1,256
New +$255K ﹤0.01% 3163

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Dimensional Fund Advisors's MCRB Position: Q1 2023 in Review

Dimensional Fund Advisors sold out of Seres Therapeutics (MCRB) in Q1 2023, closing a stake of 1,092 shares — an estimated $122 sold.

Dimensional Fund Advisors first reported a position in MCRB in Q1 2017 and held it in 7 quarters. The position peaked at $3.33M in Q1 2022. 123 funds tracked by Wall St. Rank hold MCRB as of Q1 2023.

  • Dimensional Fund Advisors reported no remaining Seres Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 1,092 Seres Therapeutics shares in Q1 2023, an estimated $122.
  • Dimensional Fund Advisors first reported a position in Seres Therapeutics in Q1 2017 and held it in 7 quarters.
  • Dimensional Fund Advisors's Seres Therapeutics position peaked at $3.33M in Q1 2022.
  • 123 funds tracked by Wall St. Rank held Seres Therapeutics as of Q1 2023.

Based on Dimensional Fund Advisors's 13F filing for Q1 2023, filed 12 May 2023.